Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Merck
Accenture
Fuji
Dow
Express Scripts
Daiichi Sankyo
Johnson and Johnson
UBS

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072018

« Back to Dashboard

NDA 072018 describes DROPERIDOL, which is a drug marketed by Abraxis Pharm, Astrazeneca, Eurohlth Intl Sarl, Hospira, Igi Labs Inc, Luitpold, Smith And Nephew, Solopak, and Watson Labs, and is included in eighteen NDAs. It is available from two suppliers. Additional details are available on the DROPERIDOL profile page.

The generic ingredient in DROPERIDOL is droperidol. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the droperidol profile page.
Summary for 072018
Tradename:DROPERIDOL
Applicant:Astrazeneca
Ingredient:droperidol
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 072018

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2.5MG/ML
Approval Date:Oct 20, 1988TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
Chubb
Cerilliant
Healthtrust
QuintilesIMS
Harvard Business School
Citi
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.